AI Medical Technology reports highly promising results from clinical study in primary care facilities to validate Dermalyser - an AI-driven support tool for diagnosing melanoma skin cancer
/PRNewswire/ -- Swedish start-up AI Medical Technology today announces results from a clinical trial conducted at 37 Swedish primary care facilities with...
Source: prnewswire.com